These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhibition of theophylline absorption by activated charcoal. Sintek C; Hendeles L; Weinberger M J Pediatr; 1979 Feb; 94(2):314-6. PubMed ID: 762633 [No Abstract] [Full Text] [Related]
6. Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers. Sörgel F; Naber KG; Jaehde U; Reiter A; Seelmann R; Sigl G Am J Med; 1989 Nov; 87(5A):62S-65S. PubMed ID: 2589388 [No Abstract] [Full Text] [Related]
7. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats. Arimori K; Nakano M J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848 [TBL] [Abstract][Full Text] [Related]
8. Effect of activated charcoal on aspirin absorption in man. Part I. Levy G; Tsuchiya T Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372 [No Abstract] [Full Text] [Related]
9. Effect of delayed administration of activated charcoal on nortriptyline absorption. Dawling S; Crome P; Braithwaite R Eur J Clin Pharmacol; 1978 Dec; 14(6):445-7. PubMed ID: 738352 [TBL] [Abstract][Full Text] [Related]
10. Inhibition by ice cream of the antidotal efficacy of activated charcoal. Levy G; Soda DM; Lampman TA Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of aspirin absorption by activated charcoal and apomorphine. Decker WJ; Shpall RA; Corby DG; Combs HF; Payne CE Clin Pharmacol Ther; 1969; 10(5):710-3. PubMed ID: 5808464 [No Abstract] [Full Text] [Related]
12. Effect of activated charcoal on absorption of tolbutamide and valproate in man. Neuvonen PJ; Kannisto H; Hirvisalo EL Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Easom JM; Caraccio TR; Lovejoy FH Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512 [TBL] [Abstract][Full Text] [Related]
15. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Neuvonen PJ; Elonen E Eur J Clin Pharmacol; 1980 Jan; 17(1):51-7. PubMed ID: 7371700 [No Abstract] [Full Text] [Related]
16. Reduction of pheniramine toxicity using activated charcoal. Boehm JJ; Brown TC; Oppenheim RC Clin Toxicol; 1978; 12(5):523-30. PubMed ID: 679637 [TBL] [Abstract][Full Text] [Related]
17. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption. Juhl RP Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570 [TBL] [Abstract][Full Text] [Related]
18. Effect of activated charcoal on acetaminophen absorption. Levy G; Houston JB Pediatrics; 1976 Sep; 58(3):432-5. PubMed ID: 958771 [TBL] [Abstract][Full Text] [Related]
19. Influence of "thickening" agents on the antidotal efficacy of activated charcoal. Gwilt PR; Perrier D Clin Toxicol; 1976; 9(1):89-92. PubMed ID: 1277772 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of activated charcoal, mineral oil, and castor oil in limiting gastrointestinal absorption of a chlorinated hydrocarbon pesticide. Morgan DP; Dotson TB; Lin LI Clin Toxicol; 1977; 11(1):61-70. PubMed ID: 68845 [No Abstract] [Full Text] [Related] [Next] [New Search]